Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1550 of 2873 entries
View as:

Quality of Life in Men With High Risk Localized Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00877617 Org: User:
Start: 05/31/06 End: 02/28/10 Due: 02/28/11

Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT01471444 Org: User:
Start: 11/02/11 End: 12/14/20 Due: 12/14/21

Early Assessment of Ovarian Cancer Aggressiveness by Metabolic Imaging

Phase: N/A Priority: Normal
NCT ID: NCT05866679 Org: User:
Start: 04/12/24 End: 08/31/28 Due: 08/31/29

Patient-Specific Computational Walking Models in Improving Surgical and Rehabilitation Treatment in Patients With Pelvic Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT05054335 Org: User:
Start: 06/20/19 End: 05/10/25 Due: 05/10/26

Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03110978 Org: User:
Start: 06/26/17 End: 06/30/26 Due: 06/30/27

Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03161522 Org: User:
Start: 02/19/18 End: 12/31/26 Due: 12/31/27

Pemetrexed Disodium in Treating Patients With Previously Treated Metastatic Urothelial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02693717 Org: User:
Start: 05/09/17 End: 12/30/19 Due: 12/30/20

Acalabrutinib and Venetoclax With or Without Early Obinutuzumab for the Treatment of High Risk, Recurrent, or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04169737 Org: User:
Start: 07/29/20 End: 07/09/26 Due: 07/09/27

Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling

Phase: N/A Priority: Normal
NCT ID: NCT05126810 Org: User:
Start: 11/03/22 End: 10/02/27 Due: 10/02/28

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00078845 Org: User:
Start: 05/31/04 End: 05/31/07 Due: 05/31/08

MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03634267 Org: User:
Start: 08/03/18 End: 12/31/26 Due: 12/31/27

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05101213 Org: User:
Start: 01/06/23 End: 01/31/27 Due: 01/31/28

Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast

Phase: N/A Priority: Normal
NCT ID: NCT03063619 Org: User:
Start: 01/30/18 End: 10/26/21 Due: 10/26/22

Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis

Phase: N/A Priority: Normal
NCT ID: NCT05062395 Org: User:
Start: 03/30/21 End: 04/04/23 Due: 04/04/24

MPDL3280A With Chemoradiation for Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02525757 Org: User:
Start: 01/26/16 End: 01/31/26 Due: 01/31/27

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

Phase: N/A Priority: Normal
NCT ID: NCT05038254 Org: User:
Start: 05/12/21 End: 01/31/26 Due: 01/31/27

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

Phase: N/A Priority: Normal
NCT ID: NCT00824811 Org: User:
Start: 06/30/09 End: - Due: -

Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04834349 Org: User:
Start: 03/09/21 End: 11/21/22 Due: 11/21/23

Trial of PBI-05204 in Advanced Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00554268 Org: User:
Start: 10/31/07 End: 04/30/13 Due: 04/30/14

Intensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage III-IVB Oropharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01893307 Org: User:
Start: 08/26/13 End: 08/31/25 Due: 08/31/26

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

Phase: N/A Priority: Normal
NCT ID: NCT05663710 Org: User:
Start: 06/30/23 End: 10/30/27 Due: 10/30/28

DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04752163 Org: User:
Start: 03/25/21 End: 11/08/23 Due: 11/08/24

Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01388777 Org: User:
Start: 01/24/12 End: 06/14/17 Due: 06/14/18

Methotrexate Infusion Into the Fourth Ventricle in Children With Malignant Fourth Ventricular Brain Tumors: A Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT01737671 Org: User:
Start: 12/27/12 End: 01/11/18 Due: 01/11/19

Cardiomyopathy Tissue Bank in a Cancer Population

Phase: N/A Priority: Normal
NCT ID: NCT00500734 Org: User:
Start: 12/10/02 End: 12/31/20 Due: 12/31/21